Source Paper
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V <sub>1b</sub> receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
Guy Griebel, Jacques Simiand, Claudine Serradeil-Le Gal, Jean Wagnon, Marc Pascal et al.
Proceedings of the National Academy of Sciences • 2002
Fear/Anxiety Defense Test Battery
Objective: An atypical anxiety model involving traumatic stress exposure to measure fear and defense-related behaviors in response to vasopressin V1b receptor antagonist treatment
Gather these items before starting the experiment. Check off items as you prepare.
Equipment5
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
Materials2
Sanofi-Synthelabo Recherche • Not specified • Not specified • Not specified
Not specified • Not specified • Not specified • Not specified
2 items available from ConductScience
Estimated: $1,890.00
As an Amazon Associate, we earn from qualifying purchases. Product links help support this free resource.